These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33880767)

  • 1. Visualising and understanding cGMP signals in the cardiovascular system.
    Feil R; Lehners M; Stehle D; Feil S
    Br J Pharmacol; 2022 Jun; 179(11):2394-2412. PubMed ID: 33880767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NO-sensitive guanylyl cyclase in the lung.
    Friebe A; Englert N
    Br J Pharmacol; 2022 Jun; 179(11):2328-2343. PubMed ID: 33332689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cGMP and mitochondrial K
    Lukowski R; Cruz Santos M; Kuret A; Ruth P
    Br J Pharmacol; 2022 Jun; 179(11):2344-2360. PubMed ID: 33991427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cGMP signalling in auditory processing in health and disease.
    Marchetta P; Rüttiger L; Hobbs AJ; Singer W; Knipper M
    Br J Pharmacol; 2022 Jun; 179(11):2378-2393. PubMed ID: 33768519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cGMP signalling in dorsal root ganglia and the spinal cord: Various functions in development and adulthood.
    Schmidt H; Böttcher A; Gross T; Schmidtko A
    Br J Pharmacol; 2022 Jun; 179(11):2361-2377. PubMed ID: 33939841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance proteins preferentially regulate natriuretic peptide-driven cGMP signalling in the heart and vasculature.
    Grange RMH; Preedy MEJ; Renukanthan A; Dignam JP; Lowe VJ; Moyes AJ; Pérez-Ternero C; Aubdool AA; Baliga RS; Hobbs AJ
    Br J Pharmacol; 2022 Jun; 179(11):2443-2459. PubMed ID: 34131904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of soluble guanylyl cyclase signalling with cinaciguat improves impaired kidney function in diabetic mice.
    Harloff M; Prüschenk S; Seifert R; Schlossmann J
    Br J Pharmacol; 2022 Jun; 179(11):2460-2475. PubMed ID: 33651375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optogenetic tools for manipulation of cyclic nucleotides functionally coupled to cyclic nucleotide-gated channels.
    Henß T; Nagpal J; Gao S; Scheib U; Pieragnolo A; Hirschhäuser A; Schneider-Warme F; Hegemann P; Nagel G; Gottschalk A
    Br J Pharmacol; 2022 Jun; 179(11):2519-2537. PubMed ID: 33733470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of cGMP signalling in tumour cells and the tumour microenvironment: Challenges and chances for cancer pharmacology and therapeutics.
    Stehle D; Barresi M; Schulz J; Feil R
    Pharmacol Ther; 2023 Feb; 242():108337. PubMed ID: 36623589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic peptides and nitric oxide stimulate cGMP synthesis in different cellular compartments.
    Piggott LA; Hassell KA; Berkova Z; Morris AP; Silberbach M; Rich TC
    J Gen Physiol; 2006 Jul; 128(1):3-14. PubMed ID: 16769793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of soluble guanylyl cyclase (sGC) by riociguat attenuates heart failure and pathological cardiac remodelling.
    Rüdebusch J; Benkner A; Nath N; Fleuch L; Kaderali L; Grube K; Klingel K; Eckstein G; Meitinger T; Fielitz J; Felix SB
    Br J Pharmacol; 2022 Jun; 179(11):2430-2442. PubMed ID: 33247945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NO as a multimodal transmitter in the brain: discovery and current status.
    Garthwaite J
    Br J Pharmacol; 2019 Jan; 176(2):197-211. PubMed ID: 30399649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cGMP signalling in cardiomyocyte microdomains.
    Bork NI; Molina CE; Nikolaev VO
    Biochem Soc Trans; 2019 Oct; 47(5):1327-1339. PubMed ID: 31652306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct submembrane localisation compartmentalises cardiac NPR1 and NPR2 signalling to cGMP.
    Subramanian H; Froese A; Jönsson P; Schmidt H; Gorelik J; Nikolaev VO
    Nat Commun; 2018 Jun; 9(1):2446. PubMed ID: 29934640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mice for cGMP imaging.
    Thunemann M; Wen L; Hillenbrand M; Vachaviolos A; Feil S; Ott T; Han X; Fukumura D; Jain RK; Russwurm M; de Wit C; Feil R
    Circ Res; 2013 Aug; 113(4):365-71. PubMed ID: 23801067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FRET-based cyclic GMP biosensors measure low cGMP concentrations in cardiomyocytes and neurons.
    Calamera G; Li D; Ulsund AH; Kim JJ; Neely OC; Moltzau LR; Bjørnerem M; Paterson D; Kim C; Levy FO; Andressen KW
    Commun Biol; 2019; 2():394. PubMed ID: 31701023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meeting report: cGMP matters.
    Kemp-Harper B; Feil R
    Sci Signal; 2008 Mar; 1(9):pe12. PubMed ID: 18319447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide and hydrogen sulfide: the gasotransmitter paradigm of the vascular system.
    Cirino G; Vellecco V; Bucci M
    Br J Pharmacol; 2017 Nov; 174(22):4021-4031. PubMed ID: 28407204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cGMP Signaling in the Cardiovascular System-The Role of Compartmentation and Its Live Cell Imaging.
    Bork NI; Nikolaev VO
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic GMP in Vascular Relaxation: Export Is of Similar Importance as Degradation.
    Krawutschke C; Koesling D; Russwurm M
    Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):2011-9. PubMed ID: 26205960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.